The Activity, Protein, and mRNA Expression of CYP2E1 and CYP3A1 in Rats after Exposure to Acute and Chronic High Altitude Hypoxia
Authors:
- 20 October 2014
- journal article
- research article
- Published by SAGE Publications in High Altitude Medicine & Biology
- Vol. 15 (4) , 491-496
Abstract
Xiangyang, Li, Xuejun Wang, Yongping Li, Junbo Zhu, Xiaodong Su, Xingchen Yao, Xueru Fan, and Yabin Duan. The activity, protein, and mRNA expression of CYP2E1 and CYP3A1 in rats after exposure to acute and chronic high altitude hypoxia. High Alt Med Biol 15:491–496, 2014.—The effects of exposure to acute and chronic high altitude hypoxia on the activity and expression of CYP2E1 and CYP3A1 were examined in rats. Rats were divided into low altitude (LA, 400 m), acute moderate altitude hypoxia (AMH, 2800 m), chronic moderate altitude hypoxia (CMH, 2800 m), acute high altitude hypoxia (AHH, 4300 m), and chronic high altitude hypoxia groups (CHH, 4300 m). Probe drugs were administrated orally to all five groups. Then the serum concentration of probe drug and its metabolite was determined by RP-HPLC. The activity of CYP2E1 and CYP3A1 was evaluated using the ratio of the metabolite to chlorzoxazone and testosterone, respectively. ELISA and real-time PCR were used to analyze the protein and mRNA expression of CYP2E1 and CYP3A1 in liver microsomes, respectively. Chronic high altitude hypoxia caused significant decreases in the activity and protein and mRNA expression of rat CYP2E1 and CYP3A1 in vivo . Acute high altitude hypoxia was not found to change the activity, protein or mRNA expression of rat CYP2E1 or CYP3A1. This study showed significant changes in the activity and protein and mRNA expression of CYP2E1 or CYP3A1 in rats after exposure to chronic high altitude hypoxia.Keywords
This publication has 31 references indexed in Scilit:
- Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in LiverDrug Metabolism and Disposition, 2007
- Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high‐throughput inhibition screening of terpenoidsRapid Communications in Mass Spectrometry, 2007
- Effect of Hypoxia on Cytochrome P450 Activity and ExpressionCurrent Drug Metabolism, 2004
- High-altitude illnessEmergency Medicine Clinics of North America, 2004
- Hypoxia‐inducible factor‐1 and activator protein‐1 modulate the upregulation of CYP3A6 induced by hypoxiaBritish Journal of Pharmacology, 2003
- Pharmacokinetics of lithium in healthy volunteers after exposure to high altitudeInt. Journal of Clinical Pharmacology and Therapeutics, 2003
- Hypoxia‐induced down‐regulation of CYP1A1/1A2 and up‐regulation of CYP3A6 involves serum mediatorsBritish Journal of Pharmacology, 2002
- Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine‐induced inflammation: the role of cytokinesBritish Journal of Pharmacology, 2000
- Genetically determined differences in drug metabolism as a risk factor in drug toxicityToxicology Letters, 1992
- Dickinson W. Richards Lecture: Circulatory adjustments to hypoxia.Circulation, 1980